Delivery Order SPE2DB25D7056-SPE2DB25FTNFM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml with a ceiling value of $2,177.06. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The contract is scheduled for ultimate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,569.12 firm fixed-price delivery order on August 28, 2025, for Ciprofloxacin-Dexamethasone otic suspension in 7.5ml units, with completion scheduled for August 29, 2025. This delivery order, which carries no set-aside designation, represents a competitively awarded transaction under the company's larger contract vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,195.90 to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with performance completion scheduled for June 4, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support...
- The Defense Logistics Agency awarded a $1,670.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5 mL quantities. This is an unset-aside, competitively awarded contract with an ultimate completion date of July 22, 2025. The delivery order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ml, with a ceiling value of $1,692.67. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and is scheduled for completion by August 15, 2025. The award represents a small-value pharmaceutical procurement typical of the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,884.78 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5ML) on August 28, 2025, with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- The Defense Logistics Agency awarded a $1,139.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL). This firm fixed-price contract, which is not set-aside designated, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed-price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 15, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL) with a ceiling value of $1,148.28. This is a firm fixed-price, non-set-aside contract utilizing a competitive procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 15, 2025. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, valued at $1,981.81 for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, is set to be completed by August 13, 2025, and will be performed at the contractor's Conshohocken facility. The contract is funded through the Defense...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNFMDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL) with a ceiling value of $17,136.44. This is a firm fixed-price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The ultimate completion date for this delivery order is September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its comprehensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. As the prime contractor under the DLA Troop Support Medical IDC, the company fulfills medical supply needs across multiple therapeutic domains to support military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare organizations. This delivery order represents one of numerous competitively awarded transactions demonstrating the contractor's capability to meet federal pharmaceutical procurement requirements on both routine and specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 9/15/25 |